KCM Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Buy
33,595
+5,534
+20% +$494K 0.1% 119
2026
Q1
$2.02M Buy
28,061
+6,491
+30% +$500K 0.07% 158
2025
Q4
$1.71M Buy
21,570
+2,350
+12% +$185K 0.05% 172
2025
Q3
$1.45M Buy
19,220
+5,649
+42% +$387K 0.05% 189
2025
Q2
$936K Sell
13,571
-936
-6% -$61.4K 0.03% 216
2025
Q1
$983K Sell
14,507
-2,062
-12% -$123K 0.04% 206
2024
Q4
$744K Sell
16,569
-2,664
-14% -$149K 0.03% 230
2024
Q3
$1.21M Sell
19,233
-1,409
-7% -$82.2K 0.04% 196
2024
Q2
$1.22M Sell
20,642
-1,453
-7% -$90.9K 0.04% 195
2024
Q1
$1.76M Sell
22,095
-5
-0% -$382 0.07% 167
2023
Q4
$1.75M Sell
22,100
-458
-2% -$32.6K 0.07% 161
2023
Q3
$1.57M Buy
22,558
+281
+1% +$19.9K 0.07% 161
2023
Q2
$1.54M Buy
22,277
+1,339
+6% +$95.3K 0.06% 176
2023
Q1
$1.56M Sell
20,938
-3,219
-13% -$270K 0.06% 178
2022
Q4
$2.25M Buy
24,157
+1,696
+8% +$164K 0.1% 147
2022
Q3
$2.14M Buy
22,461
+1,035
+5% +$102K 0.1% 149
2022
Q2
$1.99M Buy
21,426
+1,194
+6% +$117K 0.09% 156
2022
Q1
$2.05M Buy
20,232
+331
+2% +$34.8K 0.08% 167
2021
Q4
$2.05M Buy
19,901
+6,684
+51% +$618K 0.07% 170
2021
Q3
$1.12M Buy
13,217
+420
+3% +$35.2K 0.04% 199
2021
Q2
$1.07M Buy
12,797
+1,832
+17% +$150K 0.04% 200
2021
Q1
$825K Buy
10,965
+1,909
+21% +$139K 0.04% 216
2020
Q4
$619K Sell
9,056
-267
-3% -$17.4K 0.03% 218
2020
Q3
$544K Sell
9,323
-2,228
-19% -$139K 0.03% 214
2020
Q2
$750K Buy
11,551
+1,359
+13% +$85.6K 0.04% 198
2020
Q1
$605K Buy
10,192
+1,252
+14% +$83.6K 0.04% 198
2019
Q4
$664K Sell
8,940
-195
-2% -$13.7K 0.04% 216
2019
Q3
$576K Sell
9,135
-2,431
-21% -$144K 0.03% 220
2019
Q2
$630K Sell
11,566
-18,585
-62% -$1M 0.04% 211
2019
Q1
$1.63M Sell
30,151
-4,305
-12% -$266K 0.11% 141
2018
Q4
$2.26M Buy
34,456
+7,295
+27% +$545K 0.15% 133
2018
Q3
$2.14M Buy
27,161
+876
+3% +$62.6K 0.12% 149
2018
Q2
$1.69M Sell
26,285
-4,029
-13% -$266K 0.1% 169
2018
Q1
$1.89M Sell
30,314
-3,429
-10% -$246K 0.11% 168
2017
Q4
$2.45M Sell
33,743
-2,804
-8% -$204K 0.14% 147
2017
Q3
$2.97M Sell
36,547
-4,549
-11% -$360K 0.18% 133
2017
Q2
$3.31M Sell
41,096
-7,448
-15% -$588K 0.21% 123
2017
Q1
$3.81M Sell
48,544
-7,660
-14% -$612K 0.24% 110
2016
Q4
$4.43M Sell
56,204
-7,464
-12% -$604K 0.3% 93
2016
Q3
$5.67M Sell
63,668
-896
-1% -$84.6K 0.39% 73
2016
Q2
$6.18M Buy
64,564
+1,998
+3% +$199K 0.43% 67
2016
Q1
$6.49M Buy
62,566
+6,709
+12% +$652K 0.48% 56
2015
Q4
$5.46M Buy
55,857
+6,978
+14% +$683K 0.43% 63
2015
Q3
$4.72M Buy
48,879
+2,134
+5% +$224K 0.39% 78
2015
Q2
$4.9M Buy
46,745
+2,137
+5% +$218K 0.39% 74
2015
Q1
$4.6M Buy
44,608
+381
+0.9% +$38.6K 0.37% 82
2014
Q4
$4.26M Sell
44,227
-16
-0% -$1.41K 0.36% 84
2014
Q3
$3.52M Buy
44,243
+896
+2% +$70.6K 0.32% 88
2014
Q2
$3.27M Sell
43,347
-92
-0.2% -$6.95K 0.31% 97
2014
Q1
$3.25M Buy
43,439
+664
+2% +$46.9K 0.34% 92
2013
Q4
$3.06M Buy
42,775
+2,970
+7% +$191K 0.33% 92
2013
Q3
$2.26M Sell
39,805
-1,927
-5% -$115K 0.27% 113
2013
Q2
$2.39M Buy
+41,732
New +$2.42M 0.29% 104

Other funds holding CVS

KCM Investment Advisors's CVS Position: Q2 2026 in Review

KCM Investment Advisors increased its CVS Health (CVS) stake by 20% in Q2 2026, buying an estimated $494K and bringing the position to 33,595 shares worth $3.48M. The position accounts for 0.1% of the portfolio, ranked #119.

KCM Investment Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.49M in Q1 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • KCM Investment Advisors held 33,595 shares of CVS Health worth $3.48M as of Q2 2026.
  • KCM Investment Advisors bought 5,534 CVS Health shares in Q2 2026, an estimated $494K.
  • CVS Health made up 0.1% of KCM Investment Advisors's portfolio in Q2 2026, its #119 holding.
  • KCM Investment Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • KCM Investment Advisors's CVS Health position peaked at $6.49M in Q1 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.